Matthew Arentz
Physician, scientist, and global health researcher in pulmonary medicine and infectious lung disease focused on tuberculosis and COVID-19. Epidemiologist with experience in policy, outcomes research, and modeling working at the intersection of technology and healthcare. My area of focus is evaluation and validation of new technologies (particularly those that use AI) to improve access to quality diagnostics in LMICs.